title: Modulation of habit formation by levodopa in Parkinson's disease.
abstract: Dopamine promotes the execution of positively reinforced actions, but its role for the formation of behaviour when feedback is unavailable remains open. To study this issue, the performance of treated/untreated patients with Parkinson's disease and controls was analysed in an implicit learning task, hypothesising dopamine-dependent adherence to hidden task rules. Sixteen patients on/off levodopa and fourteen healthy subjects engaged in a Go/NoGo paradigm comprising four equiprobable stimuli. One of the stimuli was defined as target which was first consistently preceded by one of the three non-target stimuli (conditioning), whereas this coupling was dissolved thereafter (deconditioning). Two task versions were presented: in a 'Go version', only the target cue required the execution of a button press, whereas non-target stimuli were not instructive of a response; in a 'NoGo version', only the target cue demanded the inhibition of the button press which was demanded upon any non-target stimulus. Levodopa influenced in which task version errors grew from conditioning to deconditioning: in unmedicated patients just as controls errors only rose in the NoGo version with an increase of incorrect responses to target cues. Contrarily, in medicated patients errors went up only in the Go version with an increase of response omissions to target cues. The error increases during deconditioning can be understood as a perpetuation of reaction tendencies acquired during conditioning. The levodopa-mediated modulation of this carry-over effect suggests that dopamine supports habit conditioning under the task demand of response execution, but dampens it when inhibition is required. However, other than in reinforcement learning, supporting dopaminergic actions referred to the most frequent, i. e., non-target behaviour. Since this is passive whenever selective actions are executed against an inactive background, dopaminergic treatment could in according scenarios contribute to passive behaviour in patients with Parkinson's disease.
authors: Department of Neurology, Campus Benjamin Franklin, Charité-University Medicine Berlin, Berlin, Germany.
authors: Frank
authors: F
authors: Marzinzik
authors: Johann
authors: J
authors: Wotka
authors: Michael
authors: M
authors: Wahl
authors: Lea K
authors: LK
authors: Krugel
authors: Catarina
authors: C
authors: Kordsachia
authors: Fabian
authors: F
authors: Klostermann
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D016022:Case-Control Studies; D003213:Conditioning, Psychological / Q000187:drug effects; D003463:Cues; D004298:Dopamine / Q000378:metabolism; D015259:Dopamine Agents / Q000494:pharmacology*; D025461:Feedback, Physiological / Q000187:drug effects; D005260:Female; D006184:Habits; D006801:Humans; D007858:Learning / Q000187:drug effects*; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000378:metabolism / Q000503:physiopathology* / Q000523:psychology; D011930:Reaction Time / Q000187:drug effects
chemical_list: D015259:Dopamine Agents; D007980:Levodopa; D004298:Dopamine